期刊文献+
共找到3篇文章
< 1 >
每页显示 20 50 100
自拟消癥饮Ⅰ号方治疗异位妊娠的临床效果及对血清CA125、P、β-HCG水平的影响 被引量:3
1
作者 周瑾 程玲 《环球中医药》 CAS 2017年第9期1140-1142,共3页
目的观察自拟消癥饮Ⅰ号方治疗异位妊娠的临床效果及对血清糖类抗原125(carbohytrate antigen 125,CA125)、孕酮(progesterone,P)、β-人绒毛膜促性腺激素(β-human chorionic gonadotropin,β-HCG)水平的影响。方法将64例就诊于望京医... 目的观察自拟消癥饮Ⅰ号方治疗异位妊娠的临床效果及对血清糖类抗原125(carbohytrate antigen 125,CA125)、孕酮(progesterone,P)、β-人绒毛膜促性腺激素(β-human chorionic gonadotropin,β-HCG)水平的影响。方法将64例就诊于望京医院的异位妊娠患者随机分为对照组和观察组各32例。对照组患者给予常规西药治疗;观察组患者给予自拟消癥饮Ⅰ号方内服,连续用药7天为一个疗程。对比两组治疗的临床效果,记录治疗后月经复潮时间及盆腔包块消失时间,检测盆腔积液深度变化及盆腔包块大小变化,监测血清CA125、P、β-HCG水平。结果观察组临床疗效高达90.6%,与对照组68.8%相比显著升高(P<0.05);观察组患者经治疗后月经复潮时间、盆腔包块消失时间与对照组相比显著缩短,盆腔积液深度与对照组相比明显变少,盆腔包块大小与对照组相比明显缩小,血清CA125、P、β-HCG水平显著低于对照组患者(P<0.05)。结论自拟消癥饮Ⅰ号方治疗异位妊娠具有良好的临床效果,能有效加快月经复潮,利于缩小盆腔包块,促进盆腔包块的消失,而CA125、P、β-HCG三者水平变化是其病情转归的重要反映,值得临床推广运用。 展开更多
关键词 异位妊娠 自拟消瘾饮I号方 血清糖类抗原125 孕酮 β-人绒毛膜促性 腺激素
在线阅读 下载PDF
插拔式压电肿瘤标志物微阵列免疫传感器的研制
2
作者 张波 府伟灵 +3 位作者 蒋滢 张雪 徐世军 唐代华 《分析测试学报》 CAS CSCD 北大核心 2007年第6期779-783,788,共6页
以AT切型、基频10MHz的金膜石英晶体作为换能器,通过螺旋检测池固定夹具构建一种新型插拔式压电石英晶体传感器,并组装成2×5型压电肿瘤标志物微阵列免疫传感器。研究了传感器的响应特性及参数。该微阵列传感器在甲胎蛋白(AFP)... 以AT切型、基频10MHz的金膜石英晶体作为换能器,通过螺旋检测池固定夹具构建一种新型插拔式压电石英晶体传感器,并组装成2×5型压电肿瘤标志物微阵列免疫传感器。研究了传感器的响应特性及参数。该微阵列传感器在甲胎蛋白(AFP)、癌胚抗原(CEA)、前列腺特异性抗原(PSA)和人绒毛膜促性腺激素(hCG)质量浓度分别为20~640μg,/L、1.56~50μg/L、1.25~50μg/L、2.5~250mIU/mL的范围内,压电石英晶体振荡频率偏移值对肿瘤标志物浓度均呈现良好的响应特性。应用微阵列传感器测定68例临床血清标本,结果与化学发光免疫分析法符合(相关系数分别为0.92、0.90、0.91、0.94)。该压电肿瘤标志物传感器微阵列具有结构简单、操作方便、稳定性好、灵敏度和特异性高,不需标记,能实时检测和重复使用等优点,可用于临床实验诊断,具有临床推广应用价值。 展开更多
关键词 压电免疫传感器 微阵列 肿瘤标志物 甲胎蛋白 癌胚抗原 前列腺特异抗原 人绒毛膜促性 腺激素
在线阅读 下载PDF
Second-trimester maternal β-human chorionic gonadotropin level associated with subsequent development of pregnancy-induced hypertension 被引量:2
3
作者 Tang Longying Chen Qizhen +3 位作者 Zuo Wanxin Sun Tingwei Wang Yianshu Jin Hua 《Journal of Medical Colleges of PLA(China)》 CAS 2010年第5期293-297,共5页
Objective:To determine whether maternal β-human chorionic gonadotropin(β-hCG) level in second-trimester may be associated with subsequent development of pregnancy-induced hypertension(PIH).Methods:Seven hundred and ... Objective:To determine whether maternal β-human chorionic gonadotropin(β-hCG) level in second-trimester may be associated with subsequent development of pregnancy-induced hypertension(PIH).Methods:Seven hundred and sixty-two women in mid-trimester were to have maternal urine β-hCG standardized concentrations and maternal serum β-hCG measurements.Their case histories were recorded and reviewed from mid-trimester to delivery.The relation was observed between maternal urine,serum markers and subsequent development of PIH.Results:Among 762 women,504 cases were normal pregnancies,42 cases had PIH,94 cases had premature rupture of membrane (PROM),69 cases had preterm delivery (PD),53 other cases were excluded by various reasons.The levels of maternal urine,serum β-hCG in PIH were (61.75±9.78) IU/L and (304.56±54.17) ng/mg respectively,which were higher significantly than normal pregnancy group ([20.65±7.61] IU/L and [146.34±47.81] ng/mg,P<0.05).When maternal serum,urine β-hCG levels ≥2 MOM(multiple of mean),the incidences of developing PIH were increased significantly as compared with those of β-hCG <2 MOM women.The incidence of PIH increased from 5.1% in pregnancies with urine β-hCG ≥2 MOM to 11.7% in cases with urine β-hCG ≥4 MOM.Conclusion:The elevation of maternal mid-trimester urine,serum β-hCG levels is not only an early signal for dysfunction of placenta but also a dangerous signal for development of PIH.Second-trimester maternal urine β-hCG measurement proves to be superior to serum marker in clinical prediction. 展开更多
关键词 Second-trimester β-human chorionic gonadotropin Pregnancy-induced hypertension PLACENTA
在线阅读 下载PDF
上一页 1 下一页 到第
使用帮助 返回顶部